Literature DB >> 17007822

Biphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory pain.

Tracy A Brooks1, Scott M Ocheltree, Melissa J Seelbach, Rachael A Charles, Nicole Nametz, Richard D Egleton, Thomas P Davis.   

Abstract

The blood-brain barrier (BBB) is a dynamic system which maintains brain homeostasis and limits CNS penetration via interactions of transmembrane and intracellular proteins. Inflammatory pain (IP) is a condition underlying several diseases with known BBB perturbations, including stroke, Parkinson's, multiple sclerosis and Alzheimer's. Exploring the underlying pathology of chronic IP, we demonstrated alterations in BBB paracellular permeability with correlating changes in tight junction (TJ) proteins: occludin and claudin-5. The present study examines the IP-induced molecular changes leading to a loss in functional BBB integrity. IP was induced by injection of Complete Freund's Adjuvant (CFA) into the plantar surface of the right hindpaw of female Sprague-Dawley rats. Inflammation and hyperalgesia were confirmed, and BBB paracellular permeability was assessed by in situ brain perfusion of [14C]sucrose (paracellular diffusion marker). The permeability of the BBB was significantly increased at 24 and 72 h post-CFA. Analysis of the TJ proteins, which control the paracellular pathway, demonstrated decreased claudin-5 expression at 24 h, and an increase at 48 and 72 h post-injection. Occludin expression was significantly decreased 72 h post-CFA. Expression of junction adhesion molecule-1 (JAM-1) increased 48 h and decreased by 72 h post-CFA. Confocal microscopy demonstrated continuous expression of both occludin and JAM-1, each co-localizing with ZO-1. The increased claudin-5 expression was not limited to the junction. These results provide evidence that chronic IP causes dramatic alterations in specific cytoarchitectural proteins and demonstrate alterations in molecular properties during CFA, resulting in significant changes in BBB paracellular permeability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17007822      PMCID: PMC3893032          DOI: 10.1016/j.brainres.2006.08.085

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  61 in total

1.  Ca(2+)-independent cell-adhesion activity of claudins, a family of integral membrane proteins localized at tight junctions.

Authors:  K Kubota; M Furuse; H Sasaki; N Sonoda; K Fujita; A Nagafuchi; S Tsukita
Journal:  Curr Biol       Date:  1999-09-23       Impact factor: 10.834

2.  Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo.

Authors:  S J Bolton; D C Anthony; V H Perry
Journal:  Neuroscience       Date:  1998-10       Impact factor: 3.590

Review 3.  Overcoming barriers in the study of tight junction functions: from occludin to claudin.

Authors:  S Tsukita; M Furuse
Journal:  Genes Cells       Date:  1998-09       Impact factor: 1.891

Review 4.  To stick or not to stick: the new leukocyte homing paradigm.

Authors:  D Dunon; L Piali; B A Imhof
Journal:  Curr Opin Cell Biol       Date:  1996-10       Impact factor: 8.382

Review 5.  Drug delivery to the brain.

Authors:  W M Pardridge
Journal:  J Cereb Blood Flow Metab       Date:  1997-07       Impact factor: 6.200

Review 6.  The structure and function of blood-brain barrier in ischaemic brain stroke process.

Authors:  J Iłzecka
Journal:  Ann Univ Mariae Curie Sklodowska Med       Date:  1996

7.  Redistribution and phosphorylation of occludin during opening and resealing of tight junctions in cultured epithelial cells.

Authors:  P Farshori; B Kachar
Journal:  J Membr Biol       Date:  1999-07-15       Impact factor: 1.843

8.  Tight junction assembly during mouse blastocyst formation is regulated by late expression of ZO-1 alpha+ isoform.

Authors:  B Sheth; I Fesenko; J E Collins; B Moran; A E Wild; J M Anderson; T P Fleming
Journal:  Development       Date:  1997-05       Impact factor: 6.868

9.  Effect of lambda-carrageenan-induced inflammatory pain on brain uptake of codeine and antinociception.

Authors:  Vincent S Hau; Jason D Huber; Christopher R Campos; Ryan T Davis; Thomas P Davis
Journal:  Brain Res       Date:  2004-08-27       Impact factor: 3.252

10.  Establishment and characterization of cultured epithelial cells lacking expression of ZO-1.

Authors:  Kazuaki Umeda; Takeshi Matsui; Mayumi Nakayama; Kyoko Furuse; Hiroyuki Sasaki; Mikio Furuse; Shoichiro Tsukita
Journal:  J Biol Chem       Date:  2004-07-30       Impact factor: 5.157

View more
  17 in total

Review 1.  Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Ther Deliv       Date:  2011-08

Review 2.  Cytokine signaling modulates blood-brain barrier function.

Authors:  Weihong Pan; Kirsten P Stone; Hung Hsuchou; Vamshi K Manda; Yan Zhang; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

3.  Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier.

Authors:  Carola Förster; Malgorzata Burek; Ignacio A Romero; Babette Weksler; Pierre-Olivier Couraud; Detlev Drenckhahn
Journal:  J Physiol       Date:  2008-02-07       Impact factor: 5.182

Review 4.  Peptides at the blood brain barrier: Knowing me knowing you.

Authors:  Thomas P Davis; Thomas J Abbruscato; Richard D Egleton
Journal:  Peptides       Date:  2015-04-30       Impact factor: 3.750

5.  Inflammatory pain signals an increase in functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier.

Authors:  Patrick T Ronaldson; Jessica D Finch; Kristin M Demarco; Colleen E Quigley; Thomas P Davis
Journal:  J Pharmacol Exp Ther       Date:  2010-12-02       Impact factor: 4.030

Review 6.  Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injury.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Brain Res       Date:  2015-03-18       Impact factor: 3.252

Review 7.  Hypoxic Stress and Inflammatory Pain Disrupt Blood-Brain Barrier Tight Junctions: Implications for Drug Delivery to the Central Nervous System.

Authors:  Jeffrey J Lochhead; Patrick T Ronaldson; Thomas P Davis
Journal:  AAPS J       Date:  2017-03-28       Impact factor: 4.009

Review 8.  Engaging neuroscience to advance translational research in brain barrier biology.

Authors:  Edward A Neuwelt; Björn Bauer; Christoph Fahlke; Gert Fricker; Constantino Iadecola; Damir Janigro; Luc Leybaert; Zoltán Molnár; Martha E O'Donnell; John T Povlishock; Norman R Saunders; Frank Sharp; Danica Stanimirovic; Ryan J Watts; Lester R Drewes
Journal:  Nat Rev Neurosci       Date:  2011-03       Impact factor: 34.870

9.  von-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitis.

Authors:  Rajkumar Noubade; Roxana del Rio; Benjamin McElvany; James F Zachary; Jason M Millward; Denisa D Wagner; Halina Offner; Elizabeth P Blankenhorn; Cory Teuscher
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

10.  Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by peripheral inflammatory hyperalgesia.

Authors:  Gwen McCaffrey; Melissa J Seelbach; William D Staatz; Nicole Nametz; Carolyn Quigley; Chris R Campos; Tracy A Brooks; Thomas P Davis
Journal:  J Neurochem       Date:  2008-07-21       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.